To access Physician Decision Support please click on the following: www.beaconlbs.com/lbs-web

It appears that our website is not compatible with your browser. Please use one of the following browsers to have the best website experience: Chrome 52+, Firefox 47+, Edge 25+, Safari 9.1.2+, IE11

If IE11 does not work please check your "Compatibility Settings" and follow the instructions below:

1. Open up Internet Explorer (IE 11)

2. Press the Alt key on your keyboard, this will make a menu bar appear.

3. Click on the Tools menu tab.

4. Select the Compatibility View settings option.

5. Uncheck the "Display intranet sites in Compatibility View" option

6. Make sure to remove beaconlbs.com site from the Websites you've added to Compatibility View list

Insights / July 03, 2019 / by beaconlbs

Featured Lab-of-Choice: AmeriPath

BeaconLBS has invited the Labs-of-Choice™ to provide some more information about themselves for a blog series featuring each of the Labs-of-Choice. The following content was provided by the featured lab, AmeriPath.

AmeriPath is a leading national provider of anatomic pathology, dermatopathology and molecular diagnostic services to physicians, hospitals, clinical laboratories and surgery centers across the U.S.

Through our nationally based, board certified pathology teams and integrated state-of-the-art laboratory, AmeriPath is dedicated to providing comprehensive diagnostic solutions, advanced technology and testing, and superior pathology services to regional and local medical communities. We deliver a clearer path to greater diagnostic insights.

Our team of over 450 highly trained, board-certified pathologists and Ph.D. level scientists provide medical diagnostic services in outpatient laboratories owned, operated and managed by AmeriPath, as well as hospitals and ambulatory surgical centers.

For more information, visit AmeriPath.com.

You Might Also Like:
Liquid Biopsy in Cancer Diagnosis, Detection and Treatment

Molecular Genetics / June 11, 2019 / by beaconlbs

Liquid Biopsy in Cancer Diagnosis, Detection and Treatment

Recently, there has been much excitement about the potential for liquid biopsy’s possible applications in cancer detection, diagnosis, and treatment. Learn more about the current evidence of clinical utility of cell free DNA in our latest blog.

The Use Of PREMM5 In Identifying Risk Of Having Lynch Syndrome

Helpful Tools / January 14, 2019 / by beaconlbs

The Use Of PREMM5 In Identifying Risk Of Having Lynch Syndrome

Learn about the PREMM5 tool below and how it can help you determine if your patient needs Lynch syndrome testing.